Cameco Corporation (CCJ) – What Are Analysts Thinking About This Stock?

Cameco Corporation (NYSE:CCJ) (TSE:CCO) has received an average recommendation of “Moderate Buy” from the seventeen research firms that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, four have given a hold rating and twelve have given a buy rating to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $148.52.

Several equities analysts recently issued reports on the company. Barclays decreased their price objective on Cameco from $97.00 to $95.00 and set an “equal weight” rating for the company in a research report on Monday. Bank of America lowered their target price on Cameco from $143.00 to $140.00 and set a “buy” rating for the company in a research note on Thursday, July 9th. Truist Financial raised their target price on shares of Cameco from $129.00 to $130.00 and gave the stock a “buy” rating in a report on Wednesday, August 12th. Wall Street Zen lowered shares of Cameco from a “hold” rating to a “sell” rating in a research note on Saturday, September 19th. Finally, Royal Bank Of Canada lifted their price target on shares of Cameco from $160.00 to $175.00 and gave the company an “outperform” rating in a research note on Monday, June 29th.

Institutional Investors Weigh In On Cameco

Large investors have recently made changes to their positions in the stock. Bank of America Corp DE bought a new stake in shares of Cameco during the 2nd quarter worth approximately $735,498,000. Canada Pension Plan Investment Board acquired a new stake in shares of Cameco in the 2nd quarter valued at approximately $420,346,000. BlackRock Inc. acquired a new stake in shares of Cameco in the 2nd quarter valued at approximately $381,091,000. Cibc World Market Inc. acquired a new stake in shares of Cameco in the 2nd quarter valued at approximately $354,022,000. Finally, Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Cameco in the 2nd quarter valued at approximately $301,990,000. Institutional investors own 70.21% of the company’s stock.

Cameco Stock Down 0.3%

NYSE:CCJ opened at $80.43 on Wednesday. Cameco has a 1 year low of $77.70 and a 1 year high of $135.24. The stock has a 50-day moving average price of $93.40 and a two-hundred day moving average price of $101.07. The stock has a market cap of $35.03 billion, a price-to-earnings ratio of 91.71, a PEG ratio of 1.64 and a beta of 1.17. The company has a current ratio of 3.06, a quick ratio of 2.10 and a debt-to-equity ratio of 0.14.

Cameco (NYSE:CCJ) (TSE:CCO) last released its quarterly earnings results on Friday, July 31st. The basic materials company reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.13). The business had revenue of $573.06 million for the quarter, compared to analyst estimates of $579.60 million. Cameco had a return on equity of 7.59% and a net margin of 10.20%. The company’s revenue for the quarter was down 6.8% compared to the same quarter last year. During the same period in the prior year, the business earned $0.71 EPS. As a group, equities analysts expect that Cameco will post 1.07 earnings per share for the current year.

Cameco Company Profile

Cameco Corporation is a Canadian uranium company that explores for, mines, processes and supplies uranium used to generate nuclear power. The company produces uranium concentrates, commonly known as yellowcake, which are sold to nuclear utilities and other customers for conversion into nuclear fuel.

Cameco’s principal mining operations are located in northern Saskatchewan, including the McArthur River and Cigar Lake mines. It also operates the Key Lake uranium mill and has interests in uranium assets in Kazakhstan through the Inkai joint venture.